Immunohistochemical staining of consecutive sections of triple-negative breast cancer specimens revealed that tumor tissues expressed lower levels of BECN1, ATG16L1 and SQSTM1 than normal tissues (Figure 6c). This evidence concerns the gene ATG16L1 and neoplasm.